APA引用形式

Doi, T., Boku, N., Onozawa, Y., Takahashi, K., Kawaguchi, O., & Ohtsu, A. (2020). Phase I dose-escalation study of the safety, tolerability, and pharmacokinetics of aflibercept in combination with S-1 in Japanese patients with advanced solid malignancies. Invest New Drugs.

シカゴスタイル引用形

Doi, Toshihiko, Narikazu Boku, Yusuke Onozawa, Keishiro Takahashi, Osamu Kawaguchi, , Atsushi Ohtsu. "Phase I Dose-escalation Study of the Safety, Tolerability, and Pharmacokinetics of Aflibercept in Combination With S-1 in Japanese Patients With Advanced Solid Malignancies." Invest New Drugs 2020.

MLA引用形式

Doi, Toshihiko, et al. "Phase I Dose-escalation Study of the Safety, Tolerability, and Pharmacokinetics of Aflibercept in Combination With S-1 in Japanese Patients With Advanced Solid Malignancies." Invest New Drugs 2020.

警告: この引用は必ずしも正確ではありません.